Abstract:The emergence of mcr homologues posed a serious threat to the therapeutic efficiency of polymyxin antibiotics. Citrobacter freundii is generally regarded as an opportunistic pathogen associated with a variety of nosocomial infections. In this study, we investigated the prevalence of mcr-9 in Citrobacter spp. isolates from healthy individuals and infected patients and highlighted the importance of the rational use of antibiotics. With the globally prevailing carbapenemase-producing (CP) Citrobacter spp., polymyxin antibiotics have been reconsidered as one of the last-resort treatment options. Our study was conducted to investigate the prevalence of mcr-9 in Citrobacter species. From October to November 2021, 650 fecal samples and 215 Citrobacter isolates were collected from healthy individuals and infected patients, respectively. Isolates were screened for the presence of the mcr-9 gene by the PCR method. mcr-9-carrying strains were identified by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. Due to the susceptibility to colistin, Citrobacter spp. isolates were first induced to increase the expression of mcr-9 on China blue agar plates containing colistin and were then subjected to conjugation experiments. Whole-genome sequencing was performed on the Illumina NovaSeq PE150 system. The prevalence of mcr-9 in the Citrobacter genus from healthy guts and infected patients was 0.62% and 1.86%, respectively. In all mcr-9-positive strains, MICs of polymyxin B were observed at <= 2 mu g/mL, displaying a nonresistant phenotype. As for conjugation experiments, only one isolate successfully transferred the mcr-9 gene to Escherichia coli C600. Whole-genome sequencing showed that eight mcr-9-positive Citrobacter isolates carried mcr-9 and genes encoding resistance to beta-lactam antibiotics, including bla(CMY), bla(DHA), bla(SHV), bla(TEM), and bla(CTX-M). We also discovered that mcr-9 could be located on the pKPC-CAV1321 plasmid. Our study investigated the prevalence of mcr-9 in Citrobacter spp. in both healthy individuals and infected patients and described the carriage of mcr-9 on the pKPC-CAV1321 plasmid for the first time.IMPORTANCE The emergence of mcr homologues posed a serious threat to the therapeutic efficiency of polymyxin antibiotics. Citrobacter freundii is generally regarded as an opportunistic pathogen associated with a variety of nosocomial infections. In this study, we investigated the prevalence of mcr-9 in Citrobacter spp. isolates from healthy individuals and infected patients and highlighted the importance of the rational use of antibiotics. In addition, this epidemiological investigation is the first to describe the carriage of mcr-9 on plasmid pKPC-CAV1321 and confirms the horizontal transfer of this plasmid. Our research may shed new light on further studies of mcr-9 dissemination in humans.

Co-Occurrence of NDM-9 and MCR-1 in a Human Gut Colonized Escherichia Coli ST1011

Molecular Epidemiology and Genomic Characterization of a Plasmid-Mediated Mcr-10 and Blandm-1 Co-Harboring Multidrug-Resistant Enterobacter Asburiae.

Epidemiology and Molecular Characteristics of <i>mcr-9</i> in <i>Citrobacter</i> spp. from Healthy Individuals and Patients in China

Discovery and Characterisation of an Escherichia Coli ST206 Strain Producing NDM-5 and MCR-1 from a Patient with Acute Diarrhoea in China.

Dissemination of bla NDM-5 gene via an IncX3-type plasmid among non-clonal Escherichia coli in China

Detection of an Escherichia coli Sequence Type 167 Strain with Two Tandem Copies of blaNDM-1 in the Chromosome.

The Co-Transfer of Plasmid-Borne Colistin-Resistant Genes Mcr-1 and Mcr-3.5, the Carbapenemase Gene Blandm-5 and the 16S Methylase Gene Rmtb from Escherichia Coli

Emergence of coexistence of a novel blaNDM-5-harbouring IncI1-I plasmid and an mcr-1.1-harbouring IncHI2 plasmid in a clinical Escherichia coli isolate in China

Epidemiology and Molecular Characteristics of mcr-9 in Citrobacter spp. from Healthy Individuals and Patients in China

Coproduction of MCR-9 and NDM-1 by Colistin-Resistant Enterobacter Hormaechei Isolated from Bloodstream Infection

Complete Genomic Characterization of Two Escherichia Coli Lineages Responsible for a Cluster of Carbapenem-Resistant Infections in a Chinese Hospital

Remarkable Diversity of Escherichia coli Carrying mcr-1 from Hospital Sewage with the Identification of Two New mcr-1 Variants.

Molecular characterization of NDM-1-producing carbapenem-resistant E. cloacae complex from a tertiary hospital in Chongqing, China

Characteristics of a Colistin-Resistant Escherichia Coli ST695 Harboring the Chromosomally-Encoded Mcr-1 Gene

Emergence of a clinical isolate of E. coil ST297 co-carrying blaNDM-13 and mcr-1.1 in China

Complete Genome Sequencing and Genomic Characterization of Two Escherichia Coli Strains Co-Producing MCR-1 and NDM-1 from Bloodstream Infection

Co-occurrence of blaNDM–1 and mcr-9 in a Conjugative IncHI2/HI2A Plasmid From a Bloodstream Infection-Causing Carbapenem-Resistant Klebsiella pneumoniae

Genetic characteristic of coexisting of mcr-1 and blaNDM-5 in Escherichia coli isolates from lesion-bearing animal organs

Co-production of MCR-1 and NDM-5 in Escherichia Coli Isolated from a Colonization Case of Inpatient.

Coexistence of Blakpc-2–Incn and Mcr-1–Incx4 Plasmids in a ST48 Escherichia Coli Strain in China

Characterization of the global distribution and diversified plasmid reservoirs of the colistin resistance gene mcr-9